Global Red Biotechnology Market Size & Outlook
Global red biotechnology market, 2018-2030 (US$M)
Related Markets
Global red biotechnology market highlights
- The global red biotechnology market generated a revenue of USD 492,708.4 million in 2023 and is expected to reach USD 997,744.0 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 10.6% by 2030.
- In terms of segment, monoclonal antibodies accounted for a revenue of USD 243,959.0 million in 2023.
- Gene Therapy Products is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 492,708.4 million |
| Market revenue in 2030 | USD 997,744.0 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Gene Therapy Products |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, Vaccines, Cell-Based Immunotherapy Products, Gene Therapy Products, Cell Therapy Products, Tissue-Engineered Products, Stem Cells, Cell Culture, Viral Vector, Enzymes, Kits and Reagents, Animal Models, Molecular Diagnostics |
Other key industry trends
- In terms of revenue, the North America accounted for 37.0% of the global red biotechnology market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Norway is the fastest growing regional market and is projected to reach USD 1,901.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Red Biotechnology Market Scope
Red Biotechnology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global red biotechnology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to red biotechnology market will help companies and investors design strategic landscapes.
monoclonal antibodies was the largest segment with a revenue share of 49.51% in 2023. Horizon Databook has segmented the Global red biotechnology market based on monoclonal antibodies, polyclonal antibodies, recombinant proteins, vaccines, cell-based immunotherapy products, gene therapy products, cell therapy products, tissue-engineered products, stem cells, cell culture, viral vector, enzymes, kits and reagents, animal models, molecular diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Red Biotechnology Product Outlook (Revenue, USD Million, 2018-2030)
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Proteins
- Vaccines
- Cell-Based Immunotherapy Products
- Gene Therapy Products
- Cell Therapy Products
- Tissue-Engineered Products
- Stem Cells
- Cell Culture
- Viral Vector
- Enzymes
- Kits and Reagents
- Animal Models
- Molecular Diagnostics
- Others
- Global Red Biotechnology End-user Outlook (Revenue, USD Million, 2018-2030)
- Academic Research Institutes
- CMOs & CROs
- Pharmaceutical & Biotechnology Companies
- Others
Reasons to subscribe to Global red biotechnology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global red biotechnology market databook
-
Our clientele includes a mix of red biotechnology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global red biotechnology market , including forecasts for subscribers. This global databook contains high-level insights into Global red biotechnology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global red biotechnology market outlook statistics, by region, 2018-2030 (US$M)
Top 10 countries: Red biotechnology market size, 2023 (USD Million)
Top 10 countries: Red biotechnology market size, 2023 (USD Million)
Global red biotechnology market, by region, 2023 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
